Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | cytochrome P450 150A6 Cyp150A6 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 143A4 Cyp143A4 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium leprae | putative cytochrome p450 | 0.0099 | 0.7062 | 0.5 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0037 | 0.2278 | 0.2278 |
Mycobacterium ulcerans | cytochrome P450 191A3 Cyp191A3 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 124A1, Cyp124A1 | 0.0099 | 0.7062 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 125 Cyp125 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 132 Cyp132 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 188A3 Cyp188A3 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 139 Cyp139 | 0.0099 | 0.7062 | 0.5 |
Trypanosoma brucei | cytochrome P450, putative | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 142A3 Cyp142A3 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 138 Cyp138 | 0.0099 | 0.7062 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0011 | 0.0261 | 0.0369 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0011 | 0.0261 | 0.0369 |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | 0.0099 | 0.7062 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0099 | 0.7062 | 0.7062 |
Leishmania major | cytochrome p450-like protein | 0.0099 | 0.7062 | 0.5 |
Schistosoma mansoni | cytochrome P450 | 0.0099 | 0.7062 | 1 |
Mycobacterium ulcerans | cytochrome P450 105Q4 Cyp105Q4 | 0.0099 | 0.7062 | 0.5 |
Echinococcus multilocularis | 0.0099 | 0.7062 | 1 | |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 125A7 Cyp125A7 | 0.0099 | 0.7062 | 0.5 |
Echinococcus granulosus | cytochrome P450 2K1 | 0.0099 | 0.7062 | 1 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0099 | 0.7062 | 0.5 |
Trypanosoma brucei | Lanosterol 14-alpha demethylase | 0.0099 | 0.7062 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0099 | 0.7062 | 0.7062 |
Trypanosoma cruzi | cytochrome p450-like protein, putative | 0.0099 | 0.7062 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0099 | 0.7062 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 144 Cyp144 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 108B4 Cyp108B4 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 141 Cyp141 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 137 Cyp137 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 140A5 Cyp140A5 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 130 Cyp130 | 0.0099 | 0.7062 | 0.5 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0099 | 0.7062 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0099 | 0.7062 | 1 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0011 | 0.0261 | 0.0369 |
Loa Loa (eye worm) | cytochrome P450 | 0.0099 | 0.7062 | 0.7062 |
Mycobacterium ulcerans | cytochrome P450 136A2 Cyp136A2 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 124 Cyp124 | 0.0099 | 0.7062 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0261 | 0.0261 |
Leishmania major | lanosterol 14-alpha-demethylase, putative | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 189A7 Cyp189A7 | 0.0099 | 0.7062 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0099 | 0.7062 | 0.7062 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0011 | 0.0261 | 0.0369 |
Mycobacterium ulcerans | cytochrome P450 143A3 Cyp143A3 | 0.0099 | 0.7062 | 0.5 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0011 | 0.0261 | 0.0261 |
Mycobacterium tuberculosis | Possible cytochrome P450 135A1 Cyp135A1 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 140 Cyp140 | 0.0099 | 0.7062 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0099 | 0.7062 | 0.7062 |
Mycobacterium tuberculosis | Possible cytochrome P450 135B1 Cyp135B1 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 143 Cyp143 | 0.0099 | 0.7062 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0099 | 0.7062 | 0.7062 |
Mycobacterium ulcerans | cytochrome P450 187A4 Cyp187A4 | 0.0099 | 0.7062 | 0.5 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0099 | 0.7062 | 0.7062 |
Schistosoma mansoni | voltage-gated potassium channel | 0.004 | 0.2539 | 0.3594 |
Mycobacterium tuberculosis | Probable cytochrome P450 123 Cyp123 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 monooxygenase 142 Cyp142 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Cytochrome P450 121 Cyp121 | 0.0099 | 0.7062 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0099 | 0.7062 | 0.5 |
Brugia malayi | cytochrome P450 | 0.0099 | 0.7062 | 0.7062 |
Mycobacterium ulcerans | cytochrome P450 187A5 Cyp187A5 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 128 Cyp128 | 0.0099 | 0.7062 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.004 | 0.2539 | 0.3594 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0037 | 0.2278 | 0.3225 |
Mycobacterium ulcerans | cytochrome P450 51B1 Cyp51B1 | 0.0099 | 0.7062 | 0.5 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 126A3 Cyp126A3 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 144A4 Cyp144A4 | 0.0099 | 0.7062 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1903 | 0.1903 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0099 | 0.7062 | 0.5 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0034 | 0.2091 | 1 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0034 | 0.2091 | 1 |
Mycobacterium ulcerans | cytochrome p450 150 cyp150 | 0.0099 | 0.7062 | 0.5 |
Mycobacterium tuberculosis | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) | 0.0099 | 0.7062 | 0.5 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0011 | 0.0261 | 0.0369 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0037 | 0.2278 | 0.3225 |
Mycobacterium ulcerans | cytochrome P450 123A3 Cyp123A3 | 0.0099 | 0.7062 | 0.5 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0037 | 0.2278 | 0.2278 |
Mycobacterium tuberculosis | Possible cytochrome P450 126 Cyp126 | 0.0099 | 0.7062 | 0.5 |
Echinococcus granulosus | voltage gated potassium channel | 0.0011 | 0.0261 | 0.0369 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 30 uM | Inhibition of human recombinant GAL4N-fused VDR LBD expressed in HEK293 cells using 1,25(OH)2D3 as substrate assessed as inhibition of cofactor interaction after 16 to 18 hrs by luciferase reporter gene assay | ChEMBL. | 23294828 |
Inhibition (binding) | = 48 % | Inhibition of human recombinant GAL4N-fused VDR LBD expressed in HEK293 cells using 1,25(OH)2D3 as substrate assessed as inhibition of cofactor interaction at 30 uM after 16 to 18 hrs by luciferase reporter gene assay relative to control | ChEMBL. | 23294828 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.